Zhuzhou Qianjin Pharmaceutical Co Ltd
600479
Company Profile
Business description
Zhuzhou Qianjin Pharmaceutical Co Ltd is engaged in Chinese medicine, chemical medicine, and health supplies businesses in China. It produces medicines in the form of tablets, granules, and hard capsules. The company's products include Gynecological Qianjin Tablets (Capsules), Blood-Boosting Yimu Pills (Granules), Valsartan Capsules, Enalapril Maleate Tablets, Difenidol Hydrochloride Tablets, Silybin Meglumine Tablets, Entecavir Dispersible Tablets, Gynecological Special Cotton Towel Series, etc.
Contact
No. 801, Zhuzhou Avenue
Tianyuan District
Hunan Province
Zhuzhou412000
CHNT: +86 73122492897
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
5,270
Stocks News & Analysis
stocks
Undervalued ASX share with pathway to positive cash flow
Higher sales and a new loan facility increase our conviction.
stocks
Taiwan Semiconductor earnings: Buoyant guidance backed by voracious AI demand
We’ve raised our fair value estimate of Taiwan Semiconductor stock.
stocks
Ahead of earnings, is Netflix a buy, a sell, or fairly valued?
Watching sales growth and the potential for a major acquisition, here’s what we think of Netflix stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,226.70 | 45.90 | 0.50% |
| CAC 40 | 8,244.95 | 68.17 | -0.82% |
| DAX 40 | 25,258.99 | 93.40 | -0.37% |
| Dow JONES (US) | 49,427.59 | 14.85 | -0.03% |
| FTSE 100 | 10,223.42 | 15.52 | -0.15% |
| HKSE | 26,844.96 | 78.66 | -0.29% |
| NASDAQ | 23,543.81 | 13.79 | 0.06% |
| Nikkei 225 | 53,936.17 | 174.33 | -0.32% |
| NZX 50 Index | 13,718.10 | 58.31 | 0.43% |
| S&P 500 | 6,950.21 | 5.74 | 0.08% |
| S&P/ASX 200 | 8,903.90 | 48.10 | 0.54% |
| SSE Composite Index | 4,101.91 | 10.69 | -0.26% |